A detailed history of Empirical Finance, LLC transactions in Incyte Corp stock. As of the latest transaction made, Empirical Finance, LLC holds 6,395 shares of INCY stock, worth $371,997. This represents 0.02% of its overall portfolio holdings.

Number of Shares
6,395
Previous 6,419 0.37%
Holding current value
$371,997
Previous $370,000 1.62%
% of portfolio
0.02%
Previous 0.03%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

SELL
$56.55 - $66.59 $1,357 - $1,598
-24 Reduced 0.37%
6,395 $364,000
Q3 2023

Nov 02, 2023

BUY
$57.77 - $65.93 $35,701 - $40,744
618 Added 10.65%
6,419 $370,000
Q2 2023

Jul 27, 2023

BUY
$60.95 - $75.51 $41,080 - $50,893
674 Added 13.15%
5,801 $361,000
Q1 2023

Apr 05, 2023

BUY
$70.23 - $86.01 $17,627 - $21,588
251 Added 5.15%
5,127 $370,000
Q4 2022

Jan 24, 2023

BUY
$67.18 - $84.11 $27,543 - $34,485
410 Added 9.18%
4,876 $392,000
Q3 2022

Nov 04, 2022

BUY
$66.18 - $82.86 $49,635 - $62,145
750 Added 20.18%
4,466 $298,000
Q2 2022

Aug 01, 2022

BUY
$66.18 - $83.18 $35,406 - $44,501
535 Added 16.82%
3,716 $282,000
Q1 2022

Apr 21, 2022

BUY
$66.02 - $79.71 $26,143 - $31,565
396 Added 14.22%
3,181 $253,000
Q4 2021

Feb 04, 2022

BUY
$63.34 - $74.11 $176,401 - $206,396
2,785 New
2,785 $204,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $12.9B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Empirical Finance, LLC Portfolio

Follow Empirical Finance, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Empirical Finance, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Empirical Finance, LLC with notifications on news.